Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic
Context The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …
The impact of the COVID-19 pandemic on genitourinary cancer care: re-envisioning the future
Context The coronavirus disease 2019 (COVID-19) pandemic necessitated rapid changes in
medical practice. Many of these changes may add value to care, creating opportunities …
medical practice. Many of these changes may add value to care, creating opportunities …
Management, surveillance patterns, and costs associated with low-grade papillary stage ta non–muscle-invasive bladder cancer among older adults, 2004-2013
KK Bree, Y Shan, PJ Hensley, N Lobo, C Hu… - JAMA network …, 2022 - jamanetwork.com
Importance Low-risk non–muscle-invasive bladder cancer (NMIBC) is associated with
extremely low rates of progression and cancer-specific mortality; however, patients with low …
extremely low rates of progression and cancer-specific mortality; however, patients with low …
[HTML][HTML] Non—Muscle-invasive Bladder Cancer: Overview and Contemporary Treatment Landscape of Neoadjuvant Chemoablative Therapies
RS Matulewicz, GD Steinberg - Reviews in urology, 2020 - ncbi.nlm.nih.gov
Non—muscle-invasive bladder cancer (NMIBC) is a heterogeneous subclassification of
urothelial carcinoma with significant variation in individual risk of recurrence and …
urothelial carcinoma with significant variation in individual risk of recurrence and …
Enhanced quality and effectiveness of transurethral resection of bladder tumour in non–muscle-invasive bladder cancer: a multicentre real-world experience from …
P Mariappan, A Johnston, L Padovani, E Clark, M Trail… - European urology, 2020 - Elsevier
Background Clinical outcomes from non–muscle-invasive bladder cancer (NMIBC) are
partly determined by the quality of initial interventions. To improve and standardise treatment …
partly determined by the quality of initial interventions. To improve and standardise treatment …
Contemporary outcomes of patients with nonmuscle-invasive bladder cancer treated with bacillus Calmette-Guérin: implications for clinical trial design
Purpose: Recurrent disease after bacillus Calmette-Guérin treatment presents a therapeutic
challenge. To aid trial development, the US Food and Drug Administration defined …
challenge. To aid trial development, the US Food and Drug Administration defined …
Cancer-specific survival of patients with non-muscle-invasive bladder cancer: a population-based analysis
A Ślusarczyk, P Zapała, Ł Zapała, T Borkowski… - Annals of Surgical …, 2023 - Springer
Abstract Background and Purpose Non-muscle-invasive bladder cancer (NMIBC) constitutes
a heterogeneous group of tumors with different prognoses. This population-based study …
a heterogeneous group of tumors with different prognoses. This population-based study …
Molecular oncology of bladder cancer from inception to modern perspective
SD Lokeshwar, M Lopez, S Sarcan, K Aguilar… - Cancers, 2022 - mdpi.com
Simple Summary Bladder cancer (BC) is a common cancer that causes high morbidity and
mortality among affected patients. As a carcinogen-driven cancer, molecular oncology of BC …
mortality among affected patients. As a carcinogen-driven cancer, molecular oncology of BC …
[HTML][HTML] Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer–Full-text
B Bhindi, R Kool, GS Kulkarni… - Canadian Urological …, 2021 - ncbi.nlm.nih.gov
Bladder cancer is the fifth most common cancer worldwide. 1 In Canada, the estimated
incidence for 2020 was of 12 200 new cases, with 2600 disease-related deaths during that …
incidence for 2020 was of 12 200 new cases, with 2600 disease-related deaths during that …
Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature
Background: The aim of this paper is to discuss the impact of COVID-19 on patients with
urological malignancies (prostate cancer, bladder and upper tract urothelial cancer, kidney …
urological malignancies (prostate cancer, bladder and upper tract urothelial cancer, kidney …